Bladder cancer is the 7th most commonly diagnosed cancer in males, and ~75% of patients have non-muscle-invasive bladder carcinomas (#NMIBC). Review the #EAUGuidelines on staging
Prostate cancer is by far the most frequent cancer and is the 3rd predicted cause of all cancer deaths among males. While incidence and stage
5-10% of tumors are hereditary; due to germline mutations in different genes that imply a greater susceptibility to develop cancer. Germline genetic testing is becoming
Prostate cancer is by far the most frequent cancer and is the 3rd predicted cause of all cancer deaths among males. While incidence and stage
Primary urethral carcinoma (PUC) is classified as rare cancer, accounting for <1% of all genitourinary malignancies. Urothelial carcinoma (UC) is the predominant histological type, followed
#BladderCancer is the 7th most commonly diagnosed #cancer in males. For ~35% of patients, bladder cancer is muscle-invasive or #metastatic at presentation. Review the #EAUGuidelines on #MIBC in just one page with this #EAUUrologyCheatSheets
Androgen deprivation therapy is the most widely used systemic treatment for prostate cancer. It is the first line of treatment against advanced prostate cancer and is
Focal therapies for prostate cancer are a set of minimally invasive techniques to remove small, localised tumours in the prostate in carefully selected patients. The
Renal Cell Carcinoma (RCC) is the most common solid lesion within the kidney, accounting for approximately 90% of all kidney malignancies. Review the #EAUGuidelines on
#TesticularCancer compromises 1% of adult neoplasms and 5% of urological tumours. Its incidence has increased particularly in industrialized countries. Don’t miss this episode of #EAUUrologyCheatSheets! #EAUGuidelines
Paseo del General Martínez Campos, 17, 28010 Madrid
